Verastem, Inc. — Director's Dealing 2013

Feb 15, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Verastem, Inc. (VSTM)
CIK: 0001526119
Period of Report: 2012-12-28

Reporting Person: Westphal Christoph H (Director, Chief Executive Officer, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-12-28	Common Stock	A	25826	—	Acquired	738195	Direct
2013-02-06	Common Stock	L	100	$9.65	Acquired	738295	Direct
2013-02-06	Common Stock	L	4	$9.73	Acquired	738299	Direct
2013-02-06	Common Stock	L	200	$9.87	Acquired	738499	Direct
2013-02-06	Common Stock	L	100	$9.90	Acquired	738599	Direct
2013-02-06	Common Stock	L	98	$9.91	Acquired	738697	Direct
2013-02-06	Common Stock	L	298	$10.00	Acquired	738995	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2869841	Indirect
Common Stock	125714	Indirect

Footnotes

F1: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 20, 2012.

F2: Longwood Fund GP, LLC is the sole General Partner of Longwood Fund, L.P. Christoph Westphal, M.D., Ph.D., Richard Aldrich and Michelle Dipp, M.D., Ph.D. (collectively, the "Managers") are managers of Longwood Fund GP, LLC, and, as such, may be deemed to have shared voting and dispositive power with respect to the issuer's securities held by Longwood Fund L.P. (the "Longwood Shares"). Each of the Managers disclaims beneficial ownership of the Longwood Shares, except to the extent of their respective pecuniary interest therein, and the inclusion of the Longwood Shares in this report shall not be deemed an admission of beneficial ownership of the Longwood Shares for purposes of Section 16 or for any other purpose.